Sandoz Group AG (LON:0SAN)
London · Delayed Price · Currency is GBP · Price in CHF 50.43
+0.27 (0.54%)
At close: Aug 27, 2025
Sandoz Group AG Revenue
Sandoz Group AG had revenue of $5.27B USD in the half year ending June 30, 2025, with 6.80% growth. This brings the company's revenue in the last twelve months to $10.59B, up 4.71% year-over-year. In the year 2024, Sandoz Group AG had annual revenue of $10.38B with 4.06% growth.
Revenue (ttm)
$10.59B
Revenue Growth
+4.71%
P/S Ratio
2.59
Revenue / Employee
$480.16K
Employees
22,049
Market Cap
20.02B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.38B | 405.00M | 4.06% |
| Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
| Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
| Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
| Dec 31, 2020 | 9.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Oxford Nanopore Technologies | 183.19M |